Coagulation and thrombotic complications associated with ventricular assist devices

Clinical Advances in Hematology and Oncology

Volumn 3, Issue 10, 2005, Pages 766-768

  Goldstein, Daniel J ^a  

^a MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; LOW MOLECULAR WEIGHT HEPARIN; THROMBIN INHIBITOR;

ANTICOAGULANT THERAPY; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; CELL ADHESION; DEVICE INFECTION; ENDOTHELIUM CELL; FIBRINOLYSIS; HEART ASSIST DEVICE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART TRANSPLANTATION; HEMATOPOIETIC STEM CELL; HUMAN; NOTE; PATHOPHYSIOLOGY; THROMBOELASTOGRAPHY; THROMBOEMBOLISM; THROMBOSIS; TREATMENT PLANNING;

BLOOD COAGULATION DISORDERS; HEART-ASSIST DEVICES; HUMANS; THROMBOEMBOLISM;

EID: 28944433145     PISSN: 15430790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (10)

1. Goldstein DJ. Worldwide experience with the MicroMed DeBakey Ventricular Assist Device as a bridge to transplantation. Circulation. 2003;108(suppl 1):II272-II277.
2. Delgado R 3rd, Frazier OH, Myers TJ, et al. Direct thrombolytic therapy for intraventricular thrombosis in patients with the Jarvik 2000 left ventricular assist device. J Heart Lung Transplant. 2005;24:231-233.
3. Bond AE, Nelson K, Germany CL, Smart AN. The left ventricular assist device. Am J Nurs. 2003;103:32-40.
4. Itescu S, John R. Interactions between the recipient immune system and the left ventricular assist device surface: immunological and clinical implications. Ann Thorac Surg. 2003;75(6 suppl):S58-S65.
5. Frazier OH, Myers TJ, Jarvik RK, et al. Research and development of an implantable, axial-flow left ventricular assist device: the Jarvik 2000 Heart. Ann Thorac Surg. 2001;71(3 suppl):S125-S132.
6. McCarthy PM. HeartMate implantable left ventricular assist device: bridge to transplantation and future applications. Ann Thorac Surg. 1995;59(2 suppl):S46-S51.
7. Spanier T, Oz M, Levin H, et al. Activation of coagulation and fibrinolytic pathways in patients with left ventricular assist devices. J Thorac Cardiovasc Surg. 1996;112(4):1090-1097.
8. Scott-Burden T, Frazier OH. Cellular linings of ventricular assist devices. Ann Thorac Surg. 1995;60(6):1561-1562
9. Spanier T, Chen JM, Oz MC, Stern DM, Rose EA, Schmidt AM. Time-dependent cellular population of textured-surface left ventricular assist devices contributes to the development of a biphasic systemic procoagulant response. J Thorac Cardiovasc Surg. 1999;118(3)404-413.
10. Rose EA, Levin HR, Oz MC, et al. Artificial circulatory support with textured interior surfaces. A counterintuitive approach to minimizing thromboembolism. Ciruclation. 1994;90(5 pt 2):II87-II91.